-
1
-
-
34248185611
-
Treatment with TNF blockers and mortality risk in patients with rheumatoid arthritis
-
Jacobsson L.T., Turesson C., Nilsson J.A., et al. Treatment with TNF blockers and mortality risk in patients with rheumatoid arthritis. Ann Rheum Dis 66 (2007) 670-675
-
(2007)
Ann Rheum Dis
, vol.66
, pp. 670-675
-
-
Jacobsson, L.T.1
Turesson, C.2
Nilsson, J.A.3
-
2
-
-
34347251548
-
All-cause and cause-specific mortality in rheumatoid arthritis are not greater than expected when treated with tumour necrosis factor antagonists
-
Carmona L., Descalzo M.A., Perez-Pampin E., et al. All-cause and cause-specific mortality in rheumatoid arthritis are not greater than expected when treated with tumour necrosis factor antagonists. Ann Rheum Dis 66 (2007) 880-885
-
(2007)
Ann Rheum Dis
, vol.66
, pp. 880-885
-
-
Carmona, L.1
Descalzo, M.A.2
Perez-Pampin, E.3
-
3
-
-
0037666987
-
Anti-tumor necrosis factor alpha therapy in fifteen patients with AA amyloidosis secondary to inflammatory arthritides: a followup report of tolerability and efficacy
-
Gottenberg J.E., Merle-Vincent F., Bentaberry F., et al. Anti-tumor necrosis factor alpha therapy in fifteen patients with AA amyloidosis secondary to inflammatory arthritides: a followup report of tolerability and efficacy. Arthritis Rheum 48 (2003) 2019-2024
-
(2003)
Arthritis Rheum
, vol.48
, pp. 2019-2024
-
-
Gottenberg, J.E.1
Merle-Vincent, F.2
Bentaberry, F.3
-
4
-
-
20944451093
-
Treatment of rheumatic inflammatory disease in 25 patients with secondary amyloidosis using tumor necrosis factor alpha antagonists
-
Fernández-Nebro A., Tomero E., Ortiz-Santamaría V., et al. Treatment of rheumatic inflammatory disease in 25 patients with secondary amyloidosis using tumor necrosis factor alpha antagonists. Am J Med 118 (2005) 552-556
-
(2005)
Am J Med
, vol.118
, pp. 552-556
-
-
Fernández-Nebro, A.1
Tomero, E.2
Ortiz-Santamaría, V.3
-
5
-
-
77950623828
-
BIOBADASER: Spanish registry of adverse events of biological therapies in rheumatic diseases
-
Committee B.S. BIOBADASER: Spanish registry of adverse events of biological therapies in rheumatic diseases. Rev Esp Reumatol 29 (2002) 7
-
(2002)
Rev Esp Reumatol
, vol.29
, pp. 7
-
-
Committee, B.S.1
-
6
-
-
34250003794
-
Natural history and outcome in systemic AA amyloidosis
-
Lachmann H.J., Goodman H.J., Gilbertson J.A., et al. Natural history and outcome in systemic AA amyloidosis. N Engl J Med 356 (2007) 2361-2371
-
(2007)
N Engl J Med
, vol.356
, pp. 2361-2371
-
-
Lachmann, H.J.1
Goodman, H.J.2
Gilbertson, J.A.3
-
7
-
-
0033567210
-
Invited commentary: propensity scores
-
Joffe M.M., and Rosenbaum P.R. Invited commentary: propensity scores. Am J Epidemiol 150 (1999) 327-333
-
(1999)
Am J Epidemiol
, vol.150
, pp. 327-333
-
-
Joffe, M.M.1
Rosenbaum, P.R.2
-
8
-
-
0041653315
-
Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: a multicenter active-surveillance report
-
Gomez-Reino J.J., Carmona L., Valverde V.R., et al. Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: a multicenter active-surveillance report. Arthritis Rheum 48 (2003) 2122-2127
-
(2003)
Arthritis Rheum
, vol.48
, pp. 2122-2127
-
-
Gomez-Reino, J.J.1
Carmona, L.2
Valverde, V.R.3
-
9
-
-
23244448608
-
Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis, Tours, France, 18-22 April 2004
-
Gertz M.A., Comenzo R., Falk R.H., et al. Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis, Tours, France, 18-22 April 2004. Am J Hematol 79 (2005) 319-328
-
(2005)
Am J Hematol
, vol.79
, pp. 319-328
-
-
Gertz, M.A.1
Comenzo, R.2
Falk, R.H.3
-
10
-
-
34648846150
-
Efficacy of etanercept in patients with AA amyloidosis secondary to rheumatoid arthritis
-
Nakamura T., Higashi S., Tomoda K., et al. Efficacy of etanercept in patients with AA amyloidosis secondary to rheumatoid arthritis. Clin Exp Rheumatol 25 (2007) 518-522
-
(2007)
Clin Exp Rheumatol
, vol.25
, pp. 518-522
-
-
Nakamura, T.1
Higashi, S.2
Tomoda, K.3
-
11
-
-
0033895284
-
Presentation, survival and prognostic markers in AA amyloidosis
-
Joss N., McLaughlin K., Simpson K., and Boulton-Jones J.M. Presentation, survival and prognostic markers in AA amyloidosis. QJM 93 (2000) 535-542
-
(2000)
QJM
, vol.93
, pp. 535-542
-
-
Joss, N.1
McLaughlin, K.2
Simpson, K.3
Boulton-Jones, J.M.4
-
12
-
-
0036401462
-
Heart rate variability as a predictor of mortality in patients with AA and AL amyloidosis
-
Reyners A.K., Hazenberg B.P., Reitsma W.D., and Smit A.J. Heart rate variability as a predictor of mortality in patients with AA and AL amyloidosis. Eur Heart J 23 (2002) 157-161
-
(2002)
Eur Heart J
, vol.23
, pp. 157-161
-
-
Reyners, A.K.1
Hazenberg, B.P.2
Reitsma, W.D.3
Smit, A.J.4
-
13
-
-
0025936525
-
Secondary systemic amyloidosis: response and survival in 64 patients
-
Gertz M.A., and Kyle R.A. Secondary systemic amyloidosis: response and survival in 64 patients. Medicine (Baltimore) 70 (1991) 246-256
-
(1991)
Medicine (Baltimore)
, vol.70
, pp. 246-256
-
-
Gertz, M.A.1
Kyle, R.A.2
-
14
-
-
0021972235
-
Ten years' experience of an amyloid clinic-a clinicopathological survey
-
Browning M.J., Banks R.A., Tribe C.R., et al. Ten years' experience of an amyloid clinic-a clinicopathological survey. Q J Med 54 (1985) 213-227
-
(1985)
Q J Med
, vol.54
, pp. 213-227
-
-
Browning, M.J.1
Banks, R.A.2
Tribe, C.R.3
-
15
-
-
0015548572
-
Renal amyloidosis-a fourteen-year follow-up
-
Triger D.R., and Joekes A.M. Renal amyloidosis-a fourteen-year follow-up. Q J Med 42 (1973) 15-40
-
(1973)
Q J Med
, vol.42
, pp. 15-40
-
-
Triger, D.R.1
Joekes, A.M.2
|